🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Less than a week away! Join Stephanie Gaulding from Pharmatech Associates for an insightful discussion on the importance of proactive quality approaches and reducing the hidden costs of poor quality. Submit your questions in the registration form! hubs.la/Q02XsFDL0 #pharma

Join Alison Sathe, Hannah Rosenfeld, and Paul Hanson for two informative panels at the AFDO/RAPS Healthcare Products Collaborative 2024 AI Summit next week in Cincinnati: invt.io/1lxb2f3yla5

As we wrap up 2024 and head into 2025, we make some specific recommendations for how FDA can make progress against some of its biggest challenges: hubs.la/Q02Yrgtd0

How Much Can Poor Quality Cost You? This report calculates the cost of a bad FDA 483, and it's a surprisingly high number. hubs.la/Q02YyZ3-0 #lifescience #compliance

🌶️ This one is spicy: An "FDA inspection of API manufacturer Global Calcium Pvt. Limited, in Hosur, Tamil Nadu, India, revealed that blatant data falsification and manipulation continue to take place at factories that supply drugs to the U.S. market." hubs.la/Q02YzPp20

Using Redica Systems Site Risk Scores™️ to Predict Drug Shortages: hubs.la/Q02Zm6cR0

MedTech 2024 Highlights: A Look at iCGM Systems and CPAP Machines: hubs.la/Q02ZBvS60 by Jerry Chapman

Using Redica Systems as an early warning system - Granules India FDA 483 Includes Potential Contamination and Data Integrity Findings - will it result in a Warning Letter? hubs.la/Q02ZD0Q50

🆕 Biologics Inspection Case Studies Highlight API and Drug Product Deficiencies hubs.la/Q02_hD1f0

Before Redica Systems, nobody had combined FDA (and other agency) enforcement data with regulatory surveillance. But they go hand in hand. We heard from quality professionals that they were spending far too much time doing it manually. So we built the solution.

Redica Systems is proud to complete its SOC 2 examination with the guidance of third-party audit firm A-LIGN! This globally recognized attestation validates our commitment to critical security standards to protect and secure client data.  hubs.la/Q030d_9F0

Happy new year! Meet our team Society of Quality Assurance (SQA) Annual in Orlando in April - we'll be at booth 214. #qualityassurance #pharma

This Mylan 483 from May 2024 was our most popular single document in December: redica.com/document-store…

Have thoughts on a topic in life sciences quality and regulatory compliance? Get your name out there via the Redica Systems blog! We welcome guest posts, like those from past contributors Stephanie Gaulding, Jerry Chapman, and others. Also, if you don't already subscribe to The

Quality Assurance professionals at life sciences companies have a challenging time gathering and structuring the data they need for analysis. ❌ There are too many sources and too many different structures. ✅ Now you can get it all from one place, neatly structured so that

During a March 2024 inspection of a finished drug company in China, FDA investigators Brandy N. Lepage and Karen A. Briggs encountered company management that limited access to manufacturing areas, disallowed photography, and supplied fewer documents than requested, many of them

A recent analysis of our data found that out of 72 inspected sites that had received warning letters, 59 (82%) had been cited for CAPA, and many also struggled with related areas like complaint handling and nonconforming product controls. In this guest post, Jackie Torfin from

[NEW BLOG POST] When a Health Canada 🇨🇦 inspector shows up at your drug manufacturing facility, what are the probable inspection targets? What areas are likely to be focused on, and what are their expectations? How does Health Canada differ from FDA is these respects?

🛡️ The FDA plays a critical role in protecting patients and ensuring drug quality across the industry. But what could happen if its resources are stretched too thin? #FDA #GMP hubs.la/Q03g0G9z0